EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide. Issue 1 (8th January 2020)
- Record Type:
- Journal Article
- Title:
- EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide. Issue 1 (8th January 2020)
- Main Title:
- EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide
- Authors:
- Eissa, N.G.
Sayers, E.J.
Birch, D.
Patel, S.G.
Tsai, Y.-H.
Nielsen, H. Mørck
Jones, A.T. - Abstract:
- Abstract : Membrane-active peptides have been extensively studied to probe protein–membrane interactions, to act as antimicrobial agents and cell-penetrating peptides (CPPs) for the delivery of therapeutic agents to cells. Hundreds of membrane-active sequences acting as CPPs have now been described including bioportides that serve as single entity modifiers of cell physiology at the intracellular level. Translation of promising CPPs in pre-clinical studies have, however, been disappointing as only few identified delivery systems have progressed to clinical trials. To search for novel membrane-active peptides a sequence from the EGFR juxtamembrane region was identified (named EJP18), synthesised, and examined in its L- and D-form for its ability to mediate the delivery of a small fluorophore and whole proteins to cancer cell lines. Initial studies identified the peptide as being highly membrane-active causing extensive and rapid plasma membrane reorganisation, blebbing, and toxicity. At lower, non-toxic concentrations the peptides outperformed the well-characterised CPP octaarginine in cellular delivery capacity for a fluorophore or proteins that were associated with the peptide covalently or via ionic interactions. EJP18 thus represents a novel membrane-active peptide that may be used as a naturally derived model for biophysical protein–membrane interactions or for delivery of cargo into cells for therapeutic or diagnostic applications.
- Is Part Of:
- Biochemical journal. Volume 477:Issue 1(2020)
- Journal:
- Biochemical journal
- Issue:
- Volume 477:Issue 1(2020)
- Issue Display:
- Volume 477, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 477
- Issue:
- 1
- Issue Sort Value:
- 2020-0477-0001-0000
- Page Start:
- 45
- Page End:
- 60
- Publication Date:
- 2020-01-08
- Subjects:
- confocal microscopy -- drug delivery -- flow cytometry -- mammalian cell lines -- membrane-active peptide -- protein delivery
Biochemistry -- Periodicals
572 - Journal URLs:
- http://www.biochemj.org ↗
- DOI:
- 10.1042/BCJ20190452 ↗
- Languages:
- English
- ISSNs:
- 0264-6021
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 14857.xml